Trial Profile
Predictors of cardiac events associated with Iodofiltic-acid-I-123 in post myocardial infarction patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Iodofiltic acid I 123 (Primary)
- Indications Ischaemic heart disorders; Myocardial infarction
- Focus Diagnostic use
- 22 Nov 2016 New trial record